ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Coral Products PLC

Coral Products PLC (CRU.GB)

12.50
0.00
(0.00%)
Closed June 16 11:30AM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
12.50
Bid
11.50
Ask
13.50
Volume
0.00
12.50 Day's Range 12.50
0.00 52 Week Range 12.50
Previous Close
12.50
Open
12.50
Last Trade
Last Trade Time
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-

CRU.GB Latest News

Coral Products PLC Half-year Report

Coral Products PLC 11 December 2023 CORAL PRODUCTS PLC ("Coral" or the "Group") Interim Results Coral Products plc, a specialist in the design, manufacture and supply of...

Coral Products PLC Trading Update and Directorate Change

Coral Products PLC 29 November 2023 29 November 2023 Coral Products Plc ("CRU" or the "Company") Trading Update and Change of Director Coral Products PLC, a Group of...

Coral Products PLC Change of Nominated Adviser and Broker

Coral Products PLC 07 November 2023 7 November 2023 Coral Products Plc ("CRU" or the "Company") Change of Nominated Adviser and Broker Coral Products PLC, a specialist in the...

Coral Products PLC Transaction in Own Shares

Coral Products PLC 13 October 2023 13 October 2023 Coral Products Plc ("CRU" or the "Company") Transaction in Own Shares Coral Products PLC, a specialist in the design...

Coral Products PLC Transaction in Own Shares

Coral Products PLC 12 October 2023 12 October 2023 Coral Products Plc ("CRU" or the "Company") Transaction in Own Shares Coral Products PLC, a specialist in the design...

Coral Products PLC Transaction in Own Shares

Coral Products PLC 11 October 2023 11 October 2023 Coral Products Plc ("CRU" or the "Company") Transaction in Own Shares Coral Products PLC, a specialist in the design...

Coral Products PLC Transaction in Own Shares

Coral Products PLC 05 October 2023 5 October 2023 Coral Products Plc ("CRU" or the "Company") Transaction in Own Shares Coral Products PLC, a specialist in the design...

Coral Products PLC Transaction in Own Shares

Coral Products PLC 02 October 2023 2 October 2023 Coral Products Plc ("CRU" or the "Company") Transaction in Own Shares Coral Products PLC, a specialist in the design...

Coral Products PLC Share Buyback Programme

Coral Products PLC 29 September 2023 29 September 2023 Coral Products Plc ("CRU" or the "Company") Share Buyback Programme Coral Products PLC, a specialist in the design...

Coral Products PLC Result of General Meeting

Coral Products PLC 27 September 2023 27th September 2023 CORAL PRODUCTS PLC ('Coral' or the 'Company') Result of General Meeting The Company announces that at the General...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100012.5000DE
400012.5000DE
1200012.5000DE
2600012.5000DE
5200012.5000DE
15600012.5000DE
26000012.5000DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

Discussion

View Full Feed
02opida 02opida 5 minutes ago
FBCE
02opida 02opida 5 minutes ago
80 out this Sunday AM in Happy Valley PSU
hope4patients hope4patients 8 minutes ago
Peer reviewed JAMA article says something very different. But sure, people should listen to you- an anonymous message board poster with a clear vendetta against the company. Not surprised to see you spending your weekend posting here.

https://jamanetwork.com/journals/jamaoncology/full
NWBO
TRAPPER JIM TRAPPER JIM 8 minutes ago
You’re welcome
TRAPPER JIM TRAPPER JIM 8 minutes ago
We’re loaded with pollen over here lately
fuagf fuagf 8 minutes ago
LOLOL i think you got some pronouns mixed up there too. ;-) I think.
Kjv Kjv 9 minutes ago
Why are you responding to this guy’s messages? ….lol.


It’s very obvious he is a rookie who knows very little.
GVSI was a play from 2021 that people bought from trips ( I just never bought it cos I never liked GS). He is sounding like the stock just magically appeared in
GVSI
HGilS HGilS 9 minutes ago
@Sharkey1, Not sure that the new facility enablement is a material event they have to put a PR out for.

Originally, Nasrat had said he was looking for April for the new facility to be ready.
ELTP
SilkRoad SilkRoad 9 minutes ago
Picks up mic.

A room full of cocoons:

https://investorshub.advfn.com/uimage/uploads/2024/6/15/ogixcIMG_4816.jpeg

Hanks of silk:

https://investorshub.advfn.com/uimage/uploads/2023/12/15/yxzyvIMG_0166.jpeg

The best is yet to co
KBLB
StayHumble StayHumble 10 minutes ago
What? 1 BiLLION LessShares Brownies onDeck ✅
HIRU
sab63090 sab63090 10 minutes ago
Have a great Father's Day for some of you here!
👋
AVXL
02opida 02opida 12 minutes ago
BTCWF - Bluesky Digital Assets Corp. OTC Markets Trading Symbol Change
BTCWF
02opida 02opida 12 minutes ago
JNJ - Late-breaking results show nipocalimab significantly improves Sjogren's disease activity in a Phase 2 study
JNJ
02opida 02opida 12 minutes ago
AGIO - Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
02opida 02opida 12 minutes ago
RHHBY - Genentech's Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
RHHBY
fuagf fuagf 13 minutes ago
Yep. Sadly about all your conservatives, and ours now they are
copying Trump's GOP, come up these days is what you say - bull waste.
02opida 02opida 13 minutes ago
GME - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GameStop Corp. - GME
GME
02opida 02opida 13 minutes ago
SE - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sea Limited - SE
02opida 02opida 14 minutes ago
MGAM - MOGO Esports Signs India's Premier BGMI Team for 2024 Season
MGAM
02opida 02opida 14 minutes ago
NRIX - Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)
NRIX
JOoa0ky JOoa0ky 14 minutes ago
Calabria said it during the interview.

https://podcasts.apple.com/us/podcast/votes-verdicts/id1687098457?i=1000658510867
FNMA
02opida 02opida 14 minutes ago
REGN - Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
mascale mascale 14 minutes ago
Sarbanes-Oxley Act of 2002 (SOX) applies to publicly traded companies that are registered with the Securities and Exchange Commission (SEC) and whose shares are traded on U.S. stock exchanges or OTC markets. HIRU in filings has retained counsel for SEC matters.
HIRU